Nadine Abdelhadi

I am a passionate, self-motivated, and dedicated professional. I am passionate about helping others and making a difference in the world. I respect other cultures and I
strongly believe in the importance of collaboration, cooperation and communication between humans and countries worldwide. I am an American board certified clinical
pharmacy specialist- Pharmacotherapy specialist. I am a member of the USAID global steering group for higher education projects. I am currently an assistant
professor and a researcher . I am also the director at the Red Sea Studies Center and the director of International cooperation office at Aqaba University of Technology .I
am a certified professional trainer by the International Association for People & Performance Development organization -UK .I have worked as an institutional
review board coordinator at King Hussein Cancer Center , as a regulatory /research manager at Arab pharmaceutical industry consulting/Dar Al Dawa , consultant at
Jordanian center for pharmaceutical research and as a patent specialist at El-Hassan Business Park / Royal Scientific Society and as a liaison officer at EU SRTD II
project. I have been selected as the first clinical research ambassador by Clinerion. I have worked on many international projects funded by the USAID, European Union
(Erasmus, H2020 & FP7 projects ) and UN-ESCWA and I am currently volunteering at many international and local institutions. I am currently a volunteer expert
reviewer at the NIHR call for global health research and an expert reviewer at the U.S. Civilian Research and Development Foundation. I have provided Innovation and commercialization technical support to the UN- ESCWA –Technology Centre, Queen Rania Centre for Entrepreneurship and Qatar Foundation and I have filed a patent application at the United States Patent Office. I do have an expertise in the fields of Clinical research , teaching, clinical pharmacy, biochemistry, clinical nutrition, cosmetology, international project management, entrepreneurship, intellectual property, commercialization, innovation, and research.